Search results
Results from the WOW.Com Content Network
The ClearRx bottle design was created to replace the classic orange pill bottle, which had existed since just after World War II.Patients often did not read the information on the orange bottle label, as the text was tiny, and the company logo was usually the most emphasized text on the bottle.
A pill organiser (or pill organizer), pill container, dosette box, pillcase or pillbox is a multicompartment compliance aid for storing scheduled doses of medications. Pill organisers usually have square-shaped compartments for each day of the week, although other more compact and discreet versions have come to market, including cylindrical and ...
Designer drugs are structural or functional analogues of controlled substances that are designed to mimic the pharmacological effects of the parent drug while avoiding detection or classification as illegal.
Pill dispensers are items which release medication at specified times, to assist patients in adhering to their prescribed medication regime. They may also alert the patient that it is time to take the medication. Some devices can alert a monitoring station if the patient does not take the medication from the device promptly. [1]
The primary component of a blister pack is a cavity or pocket made from a thermoformed plastic. This usually has a backing of paperboard or a lidding seal of aluminum foil or plastic film. Blister packs are useful for protecting drugs against external factors, such as humidity and contamination for extended periods of time.
The company was founded in 2013 by TJ Parker and Elliot Cohen. [2] By 2014 the IDEO incubated company was licensed in 31 states and shipping medication in dosage packets with robots handling the packaging process. [3]
Other designer drugs were prepared for the first time in clandestine laboratories. [4] Because the efficacy and safety of these substances have not been thoroughly evaluated in animal and human trials, the use of some of these drugs may result in unexpected side effects. [5] The development of designer drugs may be considered a subfield of drug ...
Bromazolam (XLI-268) is a triazolobenzodiazepine (TBZD) which was first synthesised in 1976, but was never marketed. [2] It has subsequently been sold as a designer drug, first being definitively identified by the EMCDDA in Sweden in 2016. [3]